Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn’s disease

References

• Geremia A, Biancheri P, Allan P, et al. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13:3–10.
   PubMed Web of Science ®Google Scholar
• Basso PJ, Fonseca MT, Bonfa G, et al. Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease. Braz J Med Biol Res. 2014;47:727–737.
   PubMed Web of Science ®Google Scholar
• Nagao-Kitamoto H, Shreiner AB, Gillilland MG 3rd, et al. Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice. Cell Mol Gastroenterol Hepatol. 2016;2:468–481.
   PubMed Web of Science ®Google Scholar
• Imhann F, Vich Vila A, Bonder MJ, et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2018;67:108–119.
   PubMed Web of Science ®Google Scholar
• Moustafa A, Li W, Anderson EL, et al. Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease. Clin Transl Gastroenterol. 2018;9:e132.
   PubMed Web of Science ®Google Scholar
• Erridge C, Duncan SH, Bereswill S, et al. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One. 2010;5:e9125.
   PubMed Web of Science ®Google Scholar
• Wadwa M, Klopfleisch R, Adamczyk A, et al. IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites. Mucosal Immunol. 2016;9:1263–1277.
   PubMed Web of Science ®Google Scholar
• Roy U, Galvez EJC, Iljazovic A, et al. Distinct microbial communities trigger colitis development upon intestinal barrier damage via innate or adaptive immune cells. Cell Rep. 2017;21:994–1008.
   PubMed Web of Science ®Google Scholar
• Eastaff-Leung N, Mabarrack N, Barbour A, et al. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010;30:80–89.
   PubMed Web of Science ®Google Scholar
• Li Z, Arijs I, De Hertogh G, et al. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab. Inflamm Bowel Dis. 2010;16:1299–1310.
   PubMed Web of Science ®Google Scholar
• Lord JD, Valliant-Saunders K, Hahn H, et al. Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2. Dig Dis Sci. 2012;57:2846–2855.
   PubMed Web of Science ®Google Scholar
• Ueno A, Jijon H, Chan R, et al. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19:2522–2534.
   PubMed Web of Science ®Google Scholar
• Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685–693.
   PubMed Web of Science ®Google Scholar
• Walker AW, Sanderson JD, Churcher C, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011;11:7.
   PubMed Web of Science ®Google Scholar
• Ni J, Wu GD, Albenberg L, et al. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14:573–584.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–563.
   PubMed Web of Science ®Google Scholar
• Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut 2017;66:1039–1048.
   PubMed Web of Science ®Google Scholar
• Iliev ID, Leonardi I. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat Rev Immunol. 2017;17:635–646.
   PubMed Web of Science ®Google Scholar
• Li J, Chen D, Yu B, et al. Fungi in gastrointestinal tracts of human and mice: from community to functions. Microb Ecol. 2018;75:821–829.
   PubMed Web of Science ®Google Scholar
• Gerard R, Sendid B, Colombel JF, et al. An immunological link between Candida albicans colonization and Crohn's disease. Crit Rev Microbiol. 2015;41:135–139.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang C, Tang C, et al. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J Clin Gastroenterol. 2014;48:513–523.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Chen EZ, Baldassano RN, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe. 2015;18:489–500.
   PubMed Web of Science ®Google Scholar
• Liguori G, Lamas B, Richard ML, et al. Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients. J Crohns Colitis. 2016;10:296–305.
   PubMed Web of Science ®Google Scholar
• Zholudev A, D, Zurakowski W, Young A, et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004;99:2235–2241.
   PubMed Web of Science ®Google Scholar
• Lakatos PL, Papp M, Rieder F. Serologic antiglycan antibodies in inflammatory bowel disease. Am J Gastroenterol. 2011;106:406–412.
   PubMed Web of Science ®Google Scholar
• Hamilton AL, Kamm MA, De Cruz P, et al. Serologic antibodies in relation to outcome in postoperative Crohn's disease. J Gastroenterol Hepatol. 2017;32:1195–1203.
   PubMed Web of Science ®Google Scholar
• Bertha M, Vasantharoopan A, Kumar A, et al. IBD serology and disease outcomes in African Americans with Crohn's disease. Inflamm Bowel Dis. 2018;24:209–216.
   Web of Science ®Google Scholar
• Schwarzmaier D, Foell D, Weinhage T, et al. Peripheral monocyte functions and activation in patients with quiescent Crohn's disease. PloS One. 2013;8:e62761.
   PubMed Web of Science ®Google Scholar
• Broekman MM, Roelofs HM, Hoentjen F, et al. LPS-stimulated whole blood cytokine production is not related to disease behavior in patients with quiescent Crohn's disease. PloS One. 2015;10:e0133932.
   PubMed Web of Science ®Google Scholar
• Forcione DG, Rosen MJ, Kisiel JB, et al. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut/ 2004;53:1117–1122.
   PubMed Web of Science ®Google Scholar
• Coukos JA, Howard LA, Weinberg JM, et al. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis. Dig Dis Sci. 2012;57:1544–1553.
   PubMed Web of Science ®Google Scholar
• Gologan S, R, Iacob C, Preda R, et al. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease. J Gastrointestin Liver Dis. 2012;21:39–44.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li C, Zhao X, et al. Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis. Dig Dis Sci. 2012;57:2944–2954.
   PubMed Web of Science ®Google Scholar
• O'Donnell S, O'Sullivan M, O'Morain CA, et al. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population. Eur J Gastroenterol Hepatol. 2013;25:1464–1469.
   PubMed Web of Science ®Google Scholar
• Paul S, Boschetti G, Rinaudo-Gaujous M, et al. Association of anti-glycan antibodies and inflammatory bowel disease course. J Crohns Colitis. 2015;9:445–451.
   PubMed Web of Science ®Google Scholar
• Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for Crohn's disease. Gut. 2017;66:813–822.
   PubMed Web of Science ®Google Scholar
• Halfvarson J, Brislawn CJ, Lamendella R, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol. 2017;2:17004.
   PubMed Web of Science ®Google Scholar
• Wills ES, Jonkers DM, Savelkoul PH, et al. Fecal microbial composition of ulcerative colitis and Crohn's disease patients in remission and subsequent exacerbation. PLoS One. 2014;9:e90981.
   PubMed Web of Science ®Google Scholar
• Forbes JD, Van Domselaar G, Bernstein CN. Microbiome survey of the inflamed and noninflamed gut at different compartments within the gastrointestinal tract of inflammatory bowel disease patients. Inflamm Bowel Dis. 2016;22:817–825.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhi F. Lower level of bacteroides in the gut microbiota is associated with inflammatory bowel disease: a meta-analysis. Biomed Res Int. 2016;2016:5828959.
   PubMed Web of Science ®Google Scholar
• Bunker JJ, Flynn TM, Koval JC, et al. Innate and adaptive humoral responses coat distinct commensal bacteria with immunoglobulin A. Immunity. 2015;43:541–553.
   PubMed Web of Science ®Google Scholar
• Magri G, Comerma L, Pybus M, et al. Human secretory IgM emerges from plasma cells clonally related to gut memory B cells and targets highly diverse commensals. Immunity. 2017;47:118–134 e118.
   PubMed Web of Science ®Google Scholar
• Palm NW, de Zoete MR, Cullen TW, et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell. 2014;158:1000–1010.
   PubMed Web of Science ®Google Scholar
• Ryan JD, Silverberg MS, Xu W, et al. Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort. Aliment Pharmacol Ther. 2013;38:274–283.
   PubMed Web of Science ®Google Scholar
• Goren I, Yahav L, Tulchinsky H, et al. Serology of patients with ulcerative colitis after pouch surgery is more comparable with that of patients with Crohn's disease. Inflamm Bowel Dis. 2015;21:2289–2295.
   PubMed Web of Science ®Google Scholar
• Kelly CD, Stoehr AM, Nunn C, et al. Sexual dimorphism in immunity across animals: a meta-analysis. Ecol Lett. 2018;21:1885–1894.
   PubMed Web of Science ®Google Scholar
• Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol. 2015;294:63–69.
   PubMed Web of Science ®Google Scholar
• Trigunaite A, Dimo J, Jorgensen TN. Suppressive effects of androgens on the immune system. Cell Immunol. 2015;294:87–94.
   PubMed Web of Science ®Google Scholar
• Wilhelmson AS, M, Lantero Rodriguez A, Stubelius P, et al. Testosterone is an endogenous regulator of BAFF and splenic B cell number. Nat Commun. 2018;9:2067.
   PubMed Web of Science ®Google Scholar
• Lawrance IC, Murray K, Hall A, et al. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am J Gastroenterol. 2004;99:2186–2194.
   PubMed Web of Science ®Google Scholar
• Abu-Freha N, Badarna W, Sigal-Batikoff I, et al. ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation. BMC Gastroenterol. 2018;18:153.
   PubMed Web of Science ®Google Scholar
• Nishino K, Nishida A, Inoue R, et al. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. J Gastroenterol. 2018;53:95–106.
   PubMed Web of Science ®Google Scholar
• Oshitani N, Hato F, Matsumoto T, et al. Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease. J Gastroenterol Hepatol. 2000;15:1400–1403.
   PubMed Web of Science ®Google Scholar
• Comer SS, Jasin HE. In vitro immunomodulatory effects of sulfasalazine and its metabolites. J Rheumatol. 1988;15:580–586.
   PubMed Web of Science ®Google Scholar
• Hirohata S, Ohshima N, Yanagida T, et al. Regulation of human B cell function by sulfasalazine and its metabolites. Int Immunopharmacol. 2002;2:631–640.
   PubMed Web of Science ®Google Scholar
• Zheng H, Chen M, Li Y, et al. Modulation of gut microbiome composition and function in experimental colitis treated with sulfasalazine. Front Microbiol. 2017;8:1703.
   PubMed Web of Science ®Google Scholar
• Hoffmann C, Dollive S, Grunberg S, et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One. 2013;8:e66019.
   PubMed Web of Science ®Google Scholar
• Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol. 2014;14:405–416.
   PubMed Web of Science ®Google Scholar
• Li J, Ueno A, Fort Gasia M, et al. Profiles of lamina propria T helper cell subsets discriminate between ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2016;22:1779–1792.
   PubMed Web of Science ®Google Scholar
• West NR, Hegazy AN, Owens BMJ, et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med 2017;23:579–589.
   PubMed Web of Science ®Google Scholar
• Savic Mlakar A, Hojsak I, Jergovic M, et al. Pediatric Crohn disease is characterized by Th1 in the terminal ileum and Th1/Th17 immune response in the colon. Eur J Pediatr. 2018;177:611–616.
   PubMed Web of Science ®Google Scholar
• Bourgonje AR, von Martels JZH, de Vos P, et al. Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines. PLoS One. 2018;13:e0193202.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Yoshizaki K, Kishimoto T, et al. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol. 2000;164:4878–4882.
   PubMed Web of Science ®Google Scholar
• Atreya R, J, Mudter S, Finotto J, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med. 2000;6:583–588.
   PubMed Web of Science ®Google Scholar
• Joo S, Fukuyama Y, Park EJ, et al. Critical role of TSLP-responsive mucosal dendritic cells in the induction of nasal antigen-specific IgA response. Mucosal Immunol. 2017;10:901–911.
   PubMed Web of Science ®Google Scholar
• Shibata N, J, Kunisawa K, Hosomi Y, et al. Lymphoid tissue-resident Alcaligenes LPS induces IgA production without excessive inflammatory responses via weak TLR4 agonist activity. Mucosal Immunol. 2018;11:693–702.
   PubMed Web of Science ®Google Scholar
• Lee Y, Awasthi A, Yosef N, et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012;13:991–999.
   PubMed Web of Science ®Google Scholar
• Heink S, Yogev N, Garbers C, et al. Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells. Nat Immunol. 2017;18:74–85.
   PubMed Web of Science ®Google Scholar
• Kimura A, Naka T, Kishimoto T. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci USA. 2007;104:12099–12104.
   PubMed Web of Science ®Google Scholar
• Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121–1133.
   PubMed Web of Science ®Google Scholar
• Xu L, Kitani A, Fuss I, et al. Cutting edge: regulatory T cells induce CD4 + CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol. 2007;178:6725–6729.
   PubMed Web of Science ®Google Scholar
• Lochner M, Peduto L, Cherrier M, et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t + T cells. J Exp Med. 2008;205:1381–1393.
   PubMed Web of Science ®Google Scholar
• Zhu XM, Shi YZ, Cheng M, et al. Serum IL-6, IL-23 profile and Treg/Th17 peripheral cell populations in pediatric patients with inflammatory bowel disease. Pharmazie. 2017;72:283–287.
   PubMed Web of Science ®Google Scholar
• Rolandsdotter H, Jönsson-Videsäter K, L. Fagerberg U, et al. Mucosal cytokine profiles after induction therapy with granulocyte/monocyte apheresis in new-onset inflammatory colitis. J Pediatr Gastroenterol Nutr. 2018;66:e103–e107.
   PubMed Web of Science ®Google Scholar
• Park JS, Choi JW, Jhun J, et al. Lactobacillus acidophilus improves intestinal inflammation in an acute colitis mouse model by regulation of Th17 and Treg cell balance and fibrosis development. J Med Food. 2018;21:215–224.
   PubMed Web of Science ®Google Scholar
• Alfen JS, P, Larghi F, Facciotti N, et al. Intestinal IFN-gamma-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease. J Allergy Clin Immunol 2018;142:1537–1547.e8.
   PubMed Web of Science ®Google Scholar
• Fu ZW, Zhang ZY, Ge HY. Mesenteric injection of adipose-derived mesenchymal stem cells relieves experimentally-induced colitis in rats by regulating Th17/Treg cell balance. Am J Transl Res. 2018;10:54–66.
   PubMed Web of Science ®Google Scholar
• Hanson ML, Hixon JA, Li W, et al. Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology. 2014;146:210–221 e213.
   PubMed Web of Science ®Google Scholar
• Yin M, Yan X, Weng W, et al. Micro Integral Membrane Protein (MIMP), a newly discovered anti-inflammatory protein of Lactobacillus plantarum, enhances the gut barrier and modulates microbiota and inflammatory cytokines. Cell Physiol Biochem. 2018;45:474–490.
   PubMed Web of Science ®Google Scholar
• Park JS, Choi J, Kwon JY, et al. A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model. J Transl Med. 2018;16:37.
   PubMed Web of Science ®Google Scholar
• Veenbergen S, van Leeuwen MA, Driessen GJ, et al. Development and function of immune cells in an adolescent patient with a deficiency in the interleukin-10 receptor. J Pediatr Gastroenterol Nutr. 2017;65:e5–e15.
   PubMed Web of Science ®Google Scholar
• Chen H, Xia Y, Zhu S, et al. Lactobacillus plantarum LPOnlly alters the gut flora and attenuates colitis by inducing microbiome alteration in interleukin10 knockout mice. Mol Med Rep. 2017;16:5979–5985.
   PubMed Web of Science ®Google Scholar
• Lin Z, Wang Z, Hegarty JP, et al. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease. World J Gastroenterol. 2017;23:4897–4909.
   PubMed Web of Science ®Google Scholar
• Ebrahimi Daryani N, Saghazadeh A, Moossavi S, et al. Interleukin-4 and interleukin-10 gene polymorphisms in patients with inflammatory bowel disease. Immunol Invest. 2017;46:714–729.
   PubMed Web of Science ®Google Scholar
• Kevans D, Waterman M, Milgrom R, et al. Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis. J Gastroenterol Hepatol. 2015;30:64–70.
   PubMed Web of Science ®Google Scholar
• Waterman M, Knight J, Dinani A, et al. Predictors of outcome in ulcerative colitis. Inflamm Bowel Dis. 2015;21:2097–2105.
   PubMed Web of Science ®Google Scholar
• Olbjorn C, Cvancarova Smastuen M, Thiis-Evensen E, et al. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy. Scand J Gastroenterol. 2017;52:414–419.
   PubMed Web of Science ®Google Scholar
• Frehn L, Jansen A, Bennek E, et al. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases. PLoS One. 2014;9:e106750.
   PubMed Web of Science ®Google Scholar
• Zhang S, Luo J, Li J, et al. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience. Clin Chem Lab Med. 2017;55:865–875.
   PubMed Web of Science ®Google Scholar
• Zhang S, Luo J, Wu Z, et al. Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behcet's disease. Clin Transl Gastroenterol. 2018;9:e133.
   PubMed Web of Science ®Google Scholar
• Ott SJ, Kuhbacher T, Musfeldt M, et al. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand J Gastroenterol. 2008;43:831–841.
   PubMed Web of Science ®Google Scholar